MétaCan
Menu
Retour à la cohorte
Enregistrement W4248663963 · doi:10.1159/000371430

Message from the Editor

2015· article· en· W4248663963 sur OpenAlexaboutno aff

Notice bibliographique

RevueCerebrovascular Diseases · 2015
Typearticle
Langueen
DomaineMedicine
ThématiqueCerebrovascular and Carotid Artery Diseases
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicine

Résumé

récupéré en direct d'OpenAlex

The year 2014 has been a highly successful one in the history of both Cerebrovascular Diseases and Cerebrovascular Diseases Extra. The Editors received a steadily increasing number of excellent manuscripts from all around the globe and made a sustained effort to select the best ones based on the specific interests of our readers; this has resulted in about 17% of all submissions being accepted. In mastering this task we received continuous support from the members of the Editorial Board as well as the Ad hoc Reviewers (January 1-October 20, 2014). We appreciate their commitment and expertise. We also thank all those who left the Editorial Board this year and welcome our new colleagues as well as our new associate editors and the Managing Editor operating from the Mannheim Office after the introduction of the new software system for editorial management. Editorial Board members and Ad hoc reviewers have been responsible for all manuscripts submitted and provided detailed comments as well as recommendations for publications, which we communicate to the authors. Decisions about individual acceptance, rejection or recommendation to submit an article to our sister journal Cerebrovascular Diseases Extra have all been made only after additional extensive editorial discussion. This includes in-depth analysis done by our editors as to whether a particular submission would be rated high by our readers and whether it would offer the best chances to be referenced successfully by the scientific stroke research community, given the limitation of space and time provided by the publisher.We appreciate the continuous support and interest shown to our online sister journal Cerebrovascular Diseases Extra, which continues to offer supplementing contributions, especially novel ideas from albeit smaller studies or hypothesis generating reports to be followed by more extensive future investigations. We also encourage the link recently established with other Karger Publisher journals for the publication of Stroke Notes and Case Reports in the online open access Case Reports in Neurology and the ‘still-growing' journal Interventional Neurology. Now that we have been given the assurance that early interventional endovascular therapy may add to a better outcome of acute stroke patients, we hope that Cerebrovascular Diseases and Interventional Neurology may contribute to an extensive discussion about this therapy's utility and benefit for stroke management in addition to the so far one and only approval of iv thrombolysis 20 years ago.The journal acknowledges the continuous support received from the European Stroke Conference (ESC) and vice versa in 2014, when the ESC was attended by about 4,000 people and confirmed its role as a leading stroke conference not only in Europe but worldwide. As the official journal of the ESC, Cerebrovascular Diseases is proud to support future activities. Our mutual efforts have been rewarded by the marked increase in the value of the Impact Factor close to 4 (3.681); subsequently, since last summer, there has been an increase in the number of submissions. This could not have been achieved without the excellent cooperation from the authors, reviewers, editors and staff members at Karger Publishers, Basel.In October 2014, the ScholarOne software system was introduced for the editorial management. After minor teething problems and exchange of experience between the editorial board members, more than one hundred manuscripts were evaluated using this software even in the first two months of its installation. We hope that in due time we will be able to speed up the review process for the benefit of the authors, reviewers and our readers. By using the new system, 90% of reviewers are able to complete their reviews in less than 7 days. This is in accordance with our goal to reduce the turnaround time per manuscript to the greatest possible extent. However, we always make sure that the review process remains meticulous and as good and easy as possible for all of us to keep Cerebrovascular Diseases as an example of a fair, fast and effective way to publish new, interesting and groundbreaking scientific work. Stroke medicine is gaining more importance as people are growing older - and this is the case in many countries around the globe. Therefore, we assure you that from wherever you fight the burden of cerebrovascular diseases, your manuscripts will receive our warmest welcome.M.G. Hennerici, MannheimA.L. Abbott, Melbourne, Vic., AustraliaK. Abe, Okayama, JapanA. Abou-Chebl, Plano, Tex., USAJ.S. Ahn, Seoul, Republic of Korea M.J. Alberts, Dallas, Tex., USAK.C. Albright, Birmingham, Ala., USAA.V. Alexandrov, Memphis, Tenn., USAA. Algra, Utrecht, The NetherlandsA. Alonso, Mannheim, GermanyR. Al-Shahi Salman, Edinburgh, UKM. Alva, Washington, D.C., USAY. Arbel, Toronto, Ont., CanadaA. Arboix, Barcelona, SpainH. Arima, Sydney, N.S.W., AustraliaT. Back, Arnsdorf, GermanyD. Barone, New York, N.Y., USAP. Berlit, Essen, GermanyG.L. Bernadini, Albany, N.Y., USAL. Beslow, New Haven, Conn., USAR. Bhatia, New Delhi, IndiaJ. Biller, Maywood, Ill., USAM. Bjerke, Mölndal, SwedenD.J. Blacker, Nedlands, W.A., AustraliaE.-M. Bonin, London, UKM. Borggrefe, Mannheim, GermanyT. Brandt, Heidelberg, GermanyJ.E. Bray, Box Hill, Vic., AustraliaJ. Brisman, Lake Success, N.Y., USAC. Bushnell, Winston Salem, N.C., USAL.I. Caeiro, Lisboa, PortugalB.C. Campbell, Parkville, Vic., AustraliaJ. Carey, Minneapolis, Minn., USAA. Carolei, L'Aquila, ItalyE. Carrera, Geneva, SwitzerlandA. Charidimou, London, UKS. Chaturvedi, Detroit, Mich., USAM. Chimowitz, Charleston, S.C., USAJ.H. Choi, New York, N.Y., USAJ.W. Choi, Seoul, Republic of KoreaC.-S. Chung, Seoul, Republic of KoreaA. Conti, Messina, ItalyM. Crary, Gainesville, Fla., USAA. Culebras, Syracuse, N.Y., USAT. Cumming, Melbourne, Vic., AustraliaM. Czosnyka, Cambridge, UKA. Dávalos, Badalona, SpainP. Davis, Pensacola, Fla., USAS. De Meyer, Kortrijk, BelgiumP. De Rango, Perugia, ItalyR. Dekinderen, Maastricht, The NetherlandsA.M. Demchuk, Calgary, Alta., CanadaS. Demeyer, Kortrijk, BelgiumM.S. Dennis, Edinburgh, UKD. Deplanque, Lille, FranceC.P. Derdeyn, St. Louis, Mo., USAM. Dichgans, Munich, GermanyF. Dolmans, Utrecht, The NetherlandsD.W. Droste, Luxembourg, LuxembourgJ.D. Easton, San Francisco, Calif., USAP. Eisele, Mannheim, GermanyM. El-Koussy, Bern, SwitzerlandJ. Elmer, Pittsburgh, Pa., USAN. Englyst, Southampton, UKC.C. Enzinger, Graz, AustriaE.S. Feen, St. Louis, Mo., USAA. Ferbert, Kassel, GermanyJ. Ferrari, Wien, AustriaC. Foerch, Frankfurt am Main, GermanyG. Fraedrich, Innsbruck, AustriaJ. Frey, Phoenix, Ariz., USAM. Froehler, Nashville, Tenn., USAP. Gardois, Turin, ItalyT. Gattringer, Graz, AustriaN. Gebruers, Antwerpen, BelgiumS. Giannopoulos, Ioannina, GreeceJ.M. Gilsbach, Aaechen, GermanyC.S. Gkogkas, Athens, GreeceO. Godefroy, Amiens, FranceJ. Goldstein, Boston, Mass., USAP. Gorelick, Grand Rapids, Mich., USAM. Griebe, Mannheim, GermanyC. Groden, Mannheim, GermanyC. Gumbinger, Heidelberg, GermanyR. Gupta, Marietta, Ga., USAA.K. Gupta, Bangalore, IndiaS. Gupta, New Delhi, IndiaJ. Gutierrez, New York, N.Y., USAD. Hasan, Iowa City, Iowa, USAJ. Hatazawa, Osaka, JapanJ.C. Hemphill, San Francisco, Calif., USAT. Henzler, Mannheim, GermanyJ.H. Heo, Seoul, Republic of KoreaP.U. Heuschmann, Würzburg, GermanyT. Hirano, Yufu, JapanM. Hoffman, Tampa, Fla., USAT. Hohlfeld, Düsseldorf, GermanyM. Igase, Ehime, JapanK. Ikeda, Tokyo, JapanM. Ikram, Rotterdam, The NetherlandsK. Im, Iowa City, Iowa, USAT. Iwama, Gifu, JapanK. Iwasaki, Okayama, JapanU.R. Jensen-Kondering, Kiel, GermanyJ. Jia, Beijing, ChinaG.C. Jickling, Sacramento, Calif., USAE. Juettler, Ulm, GermanyC. Jurkovitz, Newark, N.J., USAY. Kaku, Kumamoto, JapanM.S. Kamalian, Boston, Mass., USAM. Kamouchi, Fukuoka, JapanD.-W. Kang, Seoul, Republic of KoreaM. Kaste, Helsinki, FinlandR.A. Kaya, Istanbul, TurkeyL. Kellert, Heidelberg, GermanyR. Kern, Kempten, GermanyP. Khatri, Cincinnati, Ohio, USAA. Khaw, London, Ont., CanadaB.J. Kim, Seoul, Republic of KoreaH. Kim, San Francisco, Calif., USAD.-E. Kim, Goyang, Republic of KoreaY. Kitagawa, Hachioji, JapanC. Kloetzsch, Allensbach, GermanyS.-B. Ko, Seoul, Republic of KoreaS. Koch, Miami, Fla., USAA. Koizumi, Kyoto, JapanY. Kokubo, Yamagata, JapanP. Kraft, Würzburg, GermanyG.B. Kulkarni, Bangalore, IndiaJ. Kwan, Hong Kong, Hong KongS.U. Kwon, Seoul, Republic of KoreaA.Y. Lao, Manila, PhilippinesR.M. Lazar, New York, N.Y., USAD.H. Lee, Seoul, Republic of KoreaK.B. Lee, Seoul, Republic of KoreaC. Lei, Chengdu, ChinaE.C. Leira, Iowa City, Iowa, USAR.I. Lindley, Sydney, N.S.W., AustraliaP. Lindsberg, Helsinki, FinlandM. Liu, Chengdu, ChinaR.H. Llinas, Baltimore, Md., USAE. López-Cancio, Badalona, SpainH.L. Lutsep, Portland, Oreg., USAC. MacCallum, Melbourne, Vic., AustraliaR. L. Macdonald, Toronto, Ont., CanadaI.M. Macrae, Glasgow, UKB.L. Man, Hong Kong, ChinaM. Marnane, Dublin, IrelandN. Matsukawa, Nagoya, JapanH.P. Mattle, Bern, SwitzerlandN.E. Mayo, Montreal, Que., CanadaA. Meisel, Berlin, GermanyL. Menard, Montreal, Que., CanadaA. Meretoja, Melbourne, Vic., AustraliaU. Meyding-Lamadé, Frankfurt am Main, GermanyY. Mineharu, Kobe, JapanM.C.C. Molina, Manila, PhilippinesM.-L. Mono, Bern, SwitzerlandM. Moonis, Worcester, Mass., USAT. Moulin, Besançon, FranceC.S. Moy, Bethesda, Md., USAB. Moynihan, London, UKK.W. Muir, Glasgow, UKA. Munshi, Bathinda, IndiaN. Nagaraja, Iowa City, Iowa, USAS. Namura, Atlanta, Ga., USAC.H. Nolte, Berlin, GermanyB. Norrving, Lund, SwedenK. Ogasawara, Morioka, JapanJ.M. Olivot, Palo Alto, Calif., USAJ.D. Pandian, Ludhiana, IndiaL. Pascarella, Iowa City, Iowa, USAA. Planas, Barcelona, SpainN. Poungvarin, Bangkok, ThailandW.J. Powers, Chapel Hill, N.C., USAS. Prabhakaran, Chicago, Ill., USAM. Price, Lausanne, SwitzerlandM.H. Rabadi, Oklahoma City, Okla., USAA. Radbruch, Heidelberg, GermanyN. Radman, Fribourg, SwitzerlandT. Reiff, Heidelberg, GermanyW. Reith, Homburg, GermanyB. Reuter, Freiburg, GermanyC. Riedel, Kiel, GermanyT. Riester, Mannheim, GermanyE.B. Ringelstein, Münster, GermanyT. Robinson, Leicester, UKY. Roos, Amsterdam, The NetherlandsI. Saito, Toon, JapanP. Sandercock, Edinburgh, UKG. Saposnik, Toronto, Ont., CanadaM. Sasaki, Yahaba, JapanS. Sato, Osaka, JapanT. Sauer, Mannheim, GermanyK. Schaller, Genève, SwitzerlandS.M. Schild, New Orleans, La., USAL. Schilling, Mannheim, GermanyU. Schminke, Greifswald, GermanyS. Schönberg, Mannheim, GermanyM. Schumacher, Freiburg, GermanyS. Schwab, Erlangen, GermanyT. Seifert-Held, Graz, AustriaR.J. Seitz, Düsseldorf, GermanyJ. Serrone, Cincinnati, Ohio, USAV.K. Sharma, Singapore, SingaporeK. Sheth, New Haven, Conn., USAC. Shi, Chicago, Ill., USAM. Siebler, Essen, GermanyH. Sievert, Frankfurt, GermanyR. Silbergleit, Ann Arbor, Mich., USAO.C. Singer, Frankfurt, GermanyP. Sobotková, Brno, Czech RepublicL.X. Song, Shanghai, ChinaJ.D. Spence, London, Ont., CanadaP. Srivastava, New Delhi, IndiaC. Stapf, Paris, FranceT. Steiner, Heidelberg, GermanyD.C. Suh, Seoul, Republic of KoreaS. Sukumaran, Trivandrum, IndiaH. Suzuki, Tsu, JapanY. Takagi, Kyoto, JapanM. Tanaka, Osaka, JapanT. Tatlisumak, Helsinki, FinlandA. Thiel, Montreal, Que., CanadaV. Thijs, Leuven, BelgiumD. Thompson, Edinburgh, UKY. Tomii, Kyoto, JapanD. Tschoepe, Bad Oeynhausen, GermanyG. Tsivgoulis, Birmingham, Ala., USAP.J. Tyrrell, Salford, UKH.B. van der Worp, Utrecht, The NetherlandsK. Vemmos, Athens, GreeceX. Wang, Sydney, N.S.W., AustraliaM. Wasay, Karachi, PakistanA.J. Webb, Oxford, UKL.R. Wechsler, Pittsburgh, Pa., USAJ. Weinberger, New York, N.Y., USAD.J. Werring, London, UKW. Whiteley, Edinburgh, UKS. Willems, Hamburg, GermanyJ.Z. Willey, New York, N.Y., USAL. Williams, Indianapolis, Ind., USAO. Williams, New York, N.Y., USAJ.C. Wöhrle, Koblenz, GermanyJ. Woitzik, Berlin, GermanyC. Wolfe, London, UKK.S.L. Wong, Hong Kong, ChinaC.B. Wright, Miami, Fla., USAB. Wu, Chengdu, ChinaK. Yamagishi, Tsukuba, JapanM. Yasaka, Fukuoka, JapanY. Yonekawa, Zürich, SwitzerlandB.-W. Yoon, Seoul, Republic of KoreaD. Zahuranec, Ann Arbor, Mich., USAM. Zuccarello, Cincinnati, Ohio, USAR.M. Zweifler, New Orleans, La., USA

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesCharge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Observationnel · Signal consensuel: Observationnel
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,036
Score d'incertitude au seuil1,000

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,001
Bibliométrie0,0000,000
Études des sciences et des technologies0,0000,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0010,001

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,015
Tête enseignante GPT0,238
Écart entre enseignants0,223 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeObservationnel
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2015
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueCerebrovascular DiseasesMême sujetCerebrovascular and Carotid Artery DiseasesTravaux en français237 207